Smart Eye Announces Eight Breakthrough Driver Monitoring System Design Wins for Commercial Vehicles

Smart Eye, the leading developer of Driver Monitoring System (DMS) software for the automotive industry, has in partnership with a global Tier 1 supplier received a breakthrough order from a manufacturer of vehicles in the medium to heavy-duty segment. The customer is a heavy vehicle OEM with a global manufacturing base and three renowned brands, headquartered in Europe.

The new customer is the first major heavy truck manufacturer to source Smart Eye’s technology for some of its upcoming vehicle models. As a result, this new order establishes Smart Eye in the heavy commercial vehicle segment.

The new vehicle models including Smart Eye’s technology will go into production in 2025 and ramp up significantly in 2026 when the European legislation mandating DMS in all EU vehicles comes into force. The estimated revenue for the order is SEK 150 million, based on product life cycle volume projections, with a future potential of at least SEK 400 million.

“This new order represents an important breakthrough in the heavy commercial vehicle market for Smart Eye,” said Martin Krantz, CEO and Founder of Smart Eye. “As new EU legislation mandates the implementation of DMS in all new vehicles on European roads by 2026, all major heavy vehicle manufacturers will need to move fast to procure this technology for their upcoming models. It is both expected and satisfying to see heavy vehicle manufacturers follow the example set by personal car manufacturers and choose Smart Eye for future-proofing their new vehicle models.”

Smart Eye has now received a total of up to 205 design wins from 19 OEMs. The combined estimated lifetime value from current design wins is now larger than SEK 4.015 billion. The estimated value over the product lifecycle from possible additional design wins with the car manufacturers on existing platforms is SEK 4.445 billion. 

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.